MILESTONE MEDICAL INC. (14/2023) Commencing sales of CompuFlo disposables for use in neurostimulation spinal cord implantation procedures at UTMB Health Clear Lake Campus Hospital

Postawa prawna: Art. 17 ust. 1 MAR - informacje poufne.

The Board of Directors of Milestone Medical Inc. (WAR: MMD, "the Company", "the Issuer"), today announced it has commenced commercial sales of CompuFlo disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, expanding use of CompuFlo within the institution beyond the labor and delivery department and training for residents in epidural needle placement and verification. A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.

Approval and adoption of the technology for neurostimulation spinal cord stimulator implantation follows a successful evaluation process by Dr. Patrick Karas, MD, a full-time faculty neurosurgeon at UTMB, operating at both the Galveston and Clear Lake campuses. Dr. Karas completed 10 cases using the CompuFlo Epidural system, in which he reported 100% success and no complications, while decreasing operative time by around 15 to 20 minutes per procedure.

UTMB is an institution of the University of Texas System and agency of the State of Texas. UTMB is a major academic health sciences center of global influence, with medical, nursing, health professions and graduate biomedical schools; a world-renowned research enterprise; and a growing, comprehensive health system with hospitals on four campuses.

Dr. Karas is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, Texas Association of Neurosurgeons, and the American Epilepsy Society.

The Board of Directors of the Company is pleased to announce that UTMB Health Clear Lake Campus Hospital has expanded the use of the CompuFlo Epidural beyond labor _ delivery, to now include neurostimulation spinal cord stimulator implantation procedures. In the opinion of the Board of Directors of the Company, the use of the instrument for this procedure is further evidence of the broad potential of CompuFlo based on its ability to increase efficiency, safety and predictability, thus improving patient outcomes and lowering costs, while minimizing the risk of intraoperative cerebral fluid leakage and trauma to underlying nerve roots, both potential complications of spinal cord stimulator procedures.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz